Ball L, Bronstein E, Liechti G, Maurelli A
Infect Immun. 2023; 92(1):e0017923.
PMID: 38014981
PMC: 10790821.
DOI: 10.1128/iai.00179-23.
Omeershffudin U, Kumar S
Arch Microbiol. 2023; 205(10):330.
PMID: 37688619
DOI: 10.1007/s00203-023-03663-0.
Manoharan-Basil S, Gonzalez N, Laumen J, Kenyon C
Front Microbiol. 2022; 13:793612.
PMID: 35369513
PMC: 8973304.
DOI: 10.3389/fmicb.2022.793612.
Kenyon C, Manoharan-Basil S, Van Dijck C
Antimicrob Resist Infect Control. 2020; 9(1):97.
PMID: 32605597
PMC: 7325135.
DOI: 10.1186/s13756-020-00764-z.
Rubin D, Ross J, Grad Y
Transl Res. 2020; 220:122-137.
PMID: 32119845
PMC: 7293957.
DOI: 10.1016/j.trsl.2020.02.002.
Where have all the susceptible gonococci gone? A historical review of changes in MIC distribution over the past 75 years.
Kenyon C, Laumen J, Van den Bossche D, Van Dijck C
BMC Infect Dis. 2019; 19(1):1085.
PMID: 31881862
PMC: 6935233.
DOI: 10.1186/s12879-019-4712-x.
Murine host response to Neisseria gonorrhoeae upper genital tract infection reveals a common transcriptional signature, plus distinct inflammatory responses that vary between reproductive cycle phases.
Francis I, Islam E, Gower A, Shaik-Dasthagirisaheb Y, Gray-Owen S, Wetzler L
BMC Genomics. 2018; 19(1):627.
PMID: 30134832
PMC: 6106831.
DOI: 10.1186/s12864-018-5000-7.
The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.
Brannon J, Hadjifrangiskou M
Drug Des Devel Ther. 2016; 10:1795-806.
PMID: 27313446
PMC: 4890686.
DOI: 10.2147/DDDT.S98939.
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.
Unemo M, Shafer W
Clin Microbiol Rev. 2014; 27(3):587-613.
PMID: 24982323
PMC: 4135894.
DOI: 10.1128/CMR.00010-14.
About the treatment of gonorrhea in the former Soviet Union.
Jargin S
Dermatol Pract Concept. 2013; 2(3):12.
PMID: 23785614
PMC: 3663358.
DOI: 10.5826/dpc.0203a12.
Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.
Unemo M, Shafer W
Ann N Y Acad Sci. 2012; 1230:E19-28.
PMID: 22239555
PMC: 4510988.
DOI: 10.1111/j.1749-6632.2011.06215.x.
An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.
Patel A, Chaudhry U, Sachdev D, Sachdeva P, Bala M, Saluja D
Indian J Med Res. 2011; 134:419-31.
PMID: 22089602
PMC: 3237238.
Multiple antibiotic resistance in Neisseria gonorrhoeae.
Maier T, Beilstein H, Zubrzycki L
Antimicrob Agents Chemother. 1974; 6(1):22-8.
PMID: 15828166
PMC: 429042.
DOI: 10.1128/AAC.6.1.22.
Sexually transmitted diseases in clinic patients in Lagos.
Rotimi V, Somorin A
Br J Vener Dis. 1980; 56(1):54-6.
PMID: 6892789
PMC: 1045727.
DOI: 10.1136/sti.56.1.54.
Auxotypes and antibacterial resistance to gonococci with differing susceptibilities to vancomycin.
Exner A, Shinners E, Pace P, CATLIN B
Br J Vener Dis. 1982; 58(3):166-75.
PMID: 6805849
PMC: 1046038.
DOI: 10.1136/sti.58.3.166.
Neisseria gonorrhoeae isolated from disseminated and localised infections in pre-penicillin era. Auxotypes and antibacterial drug resistances.
CATLIN B, REYN A
Br J Vener Dis. 1982; 58(3):158-65.
PMID: 6805848
PMC: 1046037.
DOI: 10.1136/sti.58.3.158.
Penicillinase-producing Neisseria gonorrhoeae in Riyadh, Saudi Arabia.
Chowdhury M, Pareek S, Mahgoub E
Br J Vener Dis. 1981; 57(4):256-8.
PMID: 6791760
PMC: 1045936.
DOI: 10.1136/sti.57.4.256.
Neisseria gonorrhoeae strains isolated in Hong Kong: in vitro susceptibility to 13 antibiotics.
Ng W, Anton P, Arnold K
Antimicrob Agents Chemother. 1981; 19(1):12-7.
PMID: 6787976
PMC: 181349.
DOI: 10.1128/AAC.19.1.12.
Antimicrobial resistance.
Bull World Health Organ. 1983; 61(3):383-94.
PMID: 6603914
PMC: 2536104.
Penicillinase-producing Neisseria gonorrhoeae isolates from different localities in south east Asia. Susceptibility to 15 antibiotics.
Ng W, Chau P, Ling J, Echeverria P, Rockhill R, Arnold K
Br J Vener Dis. 1983; 59(4):232-6.
PMID: 6409343
PMC: 1046190.
DOI: 10.1136/sti.59.4.232.